Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Watson Says It Confirms Glumetza Patent Challenge - Quick Facts

RELATED NEWS
Trade ACT now with 
4/19/2012 9:20 AM ET

Watson Pharmaceuticals, Inc. (WPI: Quote) confirmed that its subsidiary, Watson Laboratories, Inc. - Florida, filed an Abbreviated New Drug Application, or ANDA, with the U.S. Food and Drug Administration, or FDA, seeking approval to market Metformin Hydrochloride Extended-release Tablets USP, 1000 mg.

Watson's Metformin Hydrochloride Extended-release Tablets are a generic version of Depomed, Inc.'s Glumetza. Glumetza is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Click here to receive FREE breaking news email alerts for Actavis Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Consumer sentiment in the euro area increased for the sixth consecutive month in May to its strongest level since the middle of last year, preliminary data from the European Commission showed Thursday. The DG ECFIN flash estimate of the consumer confidence indicator for Eurozone came in at -21.9,... Stocks moved sharply lower at the start of trading on Thursday, extending the downward move seen over the course of the previous session. The major averages dropped firmly into negative territory, although selling pressure has waned since the open. The major averages have not seen much follow-through on their initial downward moves but remain stuck in the red. First-time claims for U.S. unemployment benefits fell by more than expected in the week ended May 18th, according to a report released by the Labor Department on Thursday. The report showed that initial jobless claims fell to 340,000, a decrease of 23,000 from the previous week's revised figure of 363,000.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.